S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
Log in

NYSE:TFX - Teleflex Stock Price, Forecast & News

$357.63
+4.02 (+1.14 %)
(As of 12/5/2019 02:21 PM ET)
Today's Range
$352.01
Now: $357.63
$357.73
50-Day Range
$319.72
MA: $339.29
$354.10
52-Week Range
$226.02
Now: $357.63
$373.90
Volume161,790 shs
Average Volume315,211 shs
Market Capitalization$16.56 billion
P/E Ratio36.12
Dividend Yield0.39%
Beta0.95
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.45 billion
Cash Flow$14.93 per share
Book Value$55.24 per share

Profitability

Net Income$200.80 million

Miscellaneous

Employees15,200
Market Cap$16.56 billion
Next Earnings Date2/20/2020 (Estimated)
OptionableOptionable

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.


Teleflex (NYSE:TFX) Frequently Asked Questions

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a dividend on Thursday, October 31st. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share on Monday, December 16th. The ex-dividend date is Thursday, November 14th. View Teleflex's Dividend History.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) released its quarterly earnings results on Thursday, October, 31st. The medical technology company reported $2.97 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.75 by $0.22. The medical technology company earned $648.32 million during the quarter, compared to analyst estimates of $643.20 million. Teleflex had a net margin of 17.36% and a return on equity of 18.81%. The business's revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.52 EPS. View Teleflex's Earnings History.

When is Teleflex's next earnings date?

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Teleflex.

What price target have analysts set for TFX?

9 brokers have issued 12 month price targets for Teleflex's stock. Their forecasts range from $345.00 to $415.00. On average, they expect Teleflex's share price to reach $386.11 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for Teleflex.

What is the consensus analysts' recommendation for Teleflex?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teleflex.

What are Wall Street analysts saying about Teleflex stock?

Here are some recent quotes from research analysts about Teleflex stock:
  • 1. According to Zacks Investment Research, "Teleflex exited the first quarter of 2019 on a solid note with better-than-expected earnings and revenues figures. The promising performance was driven by strong growth in Interventional Urology, Interventional Access and OEM. Geographically, Asia and Americas both registered strong constant currency revenue growth. We currently look forward to Urolift’s impending limited launch Japan following its Shonn approval. This apart, Teleflex announced a major reimbursement milestone for Urolift of receiving a positive coverage decision from health insurer Humana. Vascular solutions synergy is progressing well. Management also seems to be confident about its recently completed Essential Medical buyout.  On the flip side, escalating operating expenses are putting pressure on the bottom line. Tough competition and pricing pressure also weigh on the stock. Overall, in the past three months, shares of Teleflex consistently outperformed its industry." (5/14/2019)
  • 2. Needham & Company LLC analysts commented, "TFX is changing its product categories and segments and we have updated our revenue model to reflect the changes. While we are maintaining our prior total revenue and EPS estimates, we are publishing our estimates for the new product categories and segments. We view RePlas as potential sources of upside to TFX’s 2019 guidance and we reiterate our Strong Buy rating." (3/26/2019)

Has Teleflex been receiving favorable news coverage?

News headlines about TFX stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teleflex earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Teleflex.

Are investors shorting Teleflex?

Teleflex saw a increase in short interest in November. As of November 15th, there was short interest totalling 721,900 shares, an increase of 33.4% from the October 31st total of 541,000 shares. Based on an average daily trading volume, of 269,200 shares, the short-interest ratio is presently 2.7 days. Approximately 1.6% of the shares of the company are short sold. View Teleflex's Current Options Chain.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), DCP Midstream (DCP), Visa (V), Penn Virginia (PVAHQ), Alphabet (GOOG), Netflix (NFLX), JPMorgan Chase & Co. (JPM), ABIOMED (ABMD), GW Pharmaceuticals PLC- (GWPH) and Lam Research (LRCX).

Who are Teleflex's key executives?

Teleflex's management team includes the folowing people:
  • Mr. Liam J. Kelly, Pres, CEO & Director (Age 52)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 57)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 52)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, Chief Information Officer & VP

Who are Teleflex's major shareholders?

Teleflex's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (4.06%), Select Equity Group L.P. (1.40%), Parnassus Investments CA (1.05%), USS Investment Management Ltd (0.53%), Villere ST Denis J & Co. LLC (0.51%) and Carillon Tower Advisers Inc. (0.48%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View Institutional Ownership Trends for Teleflex.

Which institutional investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including USS Investment Management Ltd, Point72 Asset Management L.P., Select Equity Group L.P., Rice Hall James & Associates LLC, Russell Investments Group Ltd., First Trust Advisors LP, Man Group plc and Calamos Advisors LLC. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell. View Insider Buying and Selling for Teleflex.

Which institutional investors are buying Teleflex stock?

TFX stock was acquired by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Carillon Tower Advisers Inc., Newport Trust Co, Barclays PLC, California Public Employees Retirement System, Strs Ohio, Columbus Circle Investors and Squarepoint Ops LLC. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer and John C Heinmiller. View Insider Buying and Selling for Teleflex.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $357.63.

How big of a company is Teleflex?

Teleflex has a market capitalization of $16.56 billion and generates $2.45 billion in revenue each year. The medical technology company earns $200.80 million in net income (profit) each year or $9.90 on an earnings per share basis. Teleflex employs 15,200 workers across the globe.View Additional Information About Teleflex.

What is Teleflex's official website?

The official website for Teleflex is http://www.teleflex.com/.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]


MarketBeat Community Rating for Teleflex (NYSE TFX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  399 (Vote Outperform)
Underperform Votes:  489 (Vote Underperform)
Total Votes:  888
MarketBeat's community ratings are surveys of what our community members think about Teleflex and other stocks. Vote "Outperform" if you believe TFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel